ASCO GI 2022 Conference Coverage


 

ASCO GI 2022 Update on NIVO+ Chemo vs Chemo as 1L Treatment for Advanced GC/GEJC/EAC: Expanded Efficacy, Safety, and Subgroup Analyses From 24-month Follow-up of CheckMate 649

427 views
January 26, 2022
0 Comments
Login to view comments. Click here to Login